Share this @internewscast.com

WASHINGTON — The Supreme Court on Wednesday took up a high-stakes legal battle that could lead to a definitive decision on whether the drug most commonly used for medication abortions will continue to be easily available, including by mail.

The court agreed to weigh appeals from the Biden administration and drugmaker Danco defending several Food and Drug Administration decisions that made it easier to access and use the mifepristone pill. Danco makes the brand version of the pill, Mifeprex.

The justices will hear oral arguments early next year, with a ruling due by the end of June.

The Biden administration welcomed the court’s intervention, with White House Press Secretary Karine Jean-Pierre saying in a statement that the lower court ruling under review “threatens to undermine the FDA’s scientific independent judgment and would reimpose outdated restrictions on access to safe and effective abortion medication.”

Danco said in a statement that it remains confident in the “safety and effectiveness” of the Mifeprex, which will stay available as normal under the current FDA rules while the Supreme Court hears the case.

“The FDA actions at issue were well supported by extensive safety and effectiveness data from clinical trials and decades worth of real-world experience in millions of patients,” the company’s statement added.

The legal challenge was brought by doctors and other medical professionals represented by the conservative Christian legal group Alliance Defending Freedom.

“Every court so far has agreed that the FDA acted unlawfully in removing common-sense safeguards for women and authorizing dangerous mail-order abortions,” said Erin Hawley, one of the group’s lawyers. “We urge the Supreme Court to do the same.”

The court, which has a 6-3 conservative majority, has previously shown hostility to abortion rights, overturning the landmark abortion rights ruling Roe v. Wade last year. But in April, in an earlier stage of the litigation, the court blocked a judge’s ruling that would have completely invalidated the FDA’s approval of the drug.

The abortion pill dispute does not directly address any right to abortion, focusing instead on different legal issues about the FDA’s process for approving drugs, but the case raised questions over the court’s pledge last year to leave abortion policy to the states and the federal government.

The FDA’s original decision in 2000 to approve the drug is not at issue in the Supreme Court, with the court turning away a separate appeal raising that issue.

The court will instead focus on later FDA actions from 2016 onward that made it easier to access the pill, including the initial 2021 decision that made it available by mail, which was finalized earlier this year.

Also under review are the 2016 decisions to extend the window in which mifepristone could be used to terminate pregnancies from seven weeks’ gestation to 10 weeks and reduce the number of in-person visits for patients from three to one. In another 2016 move, the FDA altered the dosing regimen, finding that a lower dose of mifepristone was sufficient.

Another way the court could dispose of the case would be to conclude that the challengers do not have legal standing to bring their lawsuit.

In 2019, the FDA approved a generic form of the drug, which is made by GenBioPro, although that issue is not at issue at the Supreme Court.

The New Orleans-based 5th U.S. Circuit Court of Appeals in August ruled that the post-2016 FDA decisions should be put on hold because the moves “were taken without sufficient consideration of the effects those changes would have on patients.” The court ruled against the challengers on their efforts to overturn the original approval of the drug and the later decision to authorize the generic version.

Both sides then filed appeals at the Supreme Court.

The current fight over the drug dates to a November 2022 lawsuit filed by the challengers. They claim that the FDA’s 2000 approval was flawed, as were later decisions that made the drug easier to access, in part because they failed to take into account safety risks to women. 

In a sweeping decision, Texas-based U.S. District Judge Matthew Kacsmaryk in April invalidated the FDA’s original approval of the drug from more than 20 years ago. After the Supreme Court put that decision on hold while litigation continued, the appeals court narrowed the scope of Kacsmaryk’s ruling, focusing on the post-2016 changes.

The FDA-approved regimen for a medication abortion involves two drugs: mifepristone, which blocks the hormone progesterone, and misoprostol, which induces contractions. A majority of abortions in the U.S. are carried out using the pills, according to a survey conducted by the Guttmacher Institute, a research group that supports abortion rights.

Access to medication abortion, especially by mail, has become of major importance in light of the Supreme Court ruling that overturned Roe v. Wade, which has led to conservative states enacting tough restrictions that either limit or ban abortion outright. Fourteen states currently have total abortion bans, according to Guttmacher.

Share this @internewscast.com
You May Also Like
Dalai Lama says he hopes to live beyond 130 years

Dalai Lama Expresses Hopes of Living Past 130 Years

The aged Dalai Lama expressed his desire to live beyond 130 years…
Birmingham Police searching for 2 suspects involved in armed robbery

Police in Birmingham seek two suspects connected to armed robbery.

BIRMINGHAM, Ala. (WIAT) — The Birmingham Police Department is seeking assistance from…
Donald and Melania Trump on a White House balcony with an American flag.

Donald and Melania Trump Charm Audience with Heartwarming Balcony Appearance Amid Fourth of July Fireworks Celebration

DONALD Trump and Melania have warmed hearts with their PDA-packed appearance while…
Heartbroken family of late soccer player Diogo Jota arrives at funeral in Portugal

Grieving Family of Deceased Soccer Star Diogo Jota Attends His Funeral in Portugal

Liverpool’s squad gathered in the quaint Portuguese town of Gondomar on Saturday…
Trump says US will begin talks with China on possible TikTok deal as early as Monday

Trump Announces Potential TikTok Negotiations with China to Start Monday

President Trump said he will begin talks with China in coming days…
Mexico President Sheinbaum hopes deported boxer Chávez Jr. will serve time in Mexico

Mexican President Sheinbaum Wishes for Deported Boxer Chávez Jr. to Face Justice in Mexico

Mexico City — President Claudia Sheinbaum of Mexico stated on Friday that…
Grieving Caitlyn Jenner seen for first time since tragic death of longtime friend and manager, Sophia Hutchins

Caitlyn Jenner Spotted for First Time After Heartbreaking Loss of Longtime Friend and Manager, Sophia Hutchins

Caitlyn Jenner was spotted for the first time since losing her longtime…
Chicago NASCAR race today: NASCAR Xfinity Series race The Loop 110 to take off in Grant Park Saturday; Cup Series happening Sunday

Chicago NASCAR Race Update: Xfinity Series ‘The Loop 110’ Hits Grant Park Saturday; Cup Series Scheduled for Sunday

CHICAGO (WLS) — Chicago’s third NASCAR Street Race will get underway on…
Hakeem Jeffries Reemerges, Doubles Down on Democrats' Big Lie About OBBB and the American Dream

Hakeem Jeffries Resurfaces, Reinforces Democrats’ False Narrative on OBBB and the American Dream

The Democrats tell dishonest statements so often, it’s hard sometimes to rank…
'The Office' actor Craig Robinson reveals he's quitting comedy to 'focus on my true calling'

‘The Office’ Star Craig Robinson Announces Shift Away from Comedy to Pursue ‘My True Passion’

Is this a joke? Comedian Craig Robinson, best known for his role…
Woman recalls saving person's life from car fire on JTB

Heroic Woman Shares Story of Rescuing Someone from a Car Fire on JTB

JFRD called Ash Lawley a hero after she pulled a woman from…
Parents desperately seeking answers on missing campers after Texas flood

Identities Released of Three Campers Who Died as Texas Flood Death Toll Increases

Three young girls were found dead after a devastating flood swept through…